Ibuprofen Price in USA
- United States: 9,510 USD/MT
By the close of Q4FY2023, ibuprofen prices in the USA reached 9510 USD/MT. Throughout the final quarter of 2023, there was an overall decrease in ibuprofen prices in the United States.
The latest report by IMARC, titled "Ibuprofen Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data" delivers a comprehensive analysis of ibuprofen prices on a global and regional scale, highlighting the pivotal factors contributing to price changes. This detailed examination includes spot price evaluations at key ports and an analysis of pricing structures, such as Ex Works, FOB, and CIF, across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Ibuprofen Prices December 2023:
- United States: 9,510 USD/MT
- China: 21,515 USD/MT (USP FDA)
- Germany: 9,870 USD/MT (USP FDA)
Report Offering:
- Monthly Updates: Annual Subscription
- Quarterly Updates: Annual Subscription
- Biannually Updates: Annual Subscription
The study delves into the factors affecting ibuprofen price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.
The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.
Request For a Sample Copy of the Report: https://www.imarcgroup.com/ibuprofen-pricing-report/requestsample
Ibuprofen Price Trend- Q4 2023
The burgeoning demand for effective pain management solutions is one of the key factors driving the global market growth of ibuprofen. This widely used non-steroidal anti-inflammatory drug (NSAID) is favored for its efficacy in reducing inflammation, pain, and fever, catering to a broad spectrum of conditions from mild to moderate pain, including arthritis, menstrual pain, and general discomfort. Moreover, the rising prevalence of chronic diseases such as arthritis and the increasing global geriatric population are major growth inducers for the ibuprofen market. In addition to this, the expansion of the pharmaceutical industry is propelling the demand for ibuprofen as companies continuously seek to innovate and improve formulations to enhance patient compliance and effectiveness. The consumer preference for over the counter (OTC) medications for quick pain relief is further stimulating market growth, as ibuprofen is a staple in home medicine cabinets. Besides this, advancements in pharmaceutical technologies that improve the solubility and absorption of ibuprofen contribute significantly to its market expansion. Furthermore, the increasing use of ibuprofen in combination drug therapies and its incorporation into gel, cream, and other topical formulations is broadening its applications and, consequently, its market reach. Regulations supporting the safe use of pain management solutions are also fostering a positive environment for the ibuprofen market. Additionally, consumer trend towards self-medication and the accessibility of ibuprofen in various dosages and formulations are amplifying its global consumption. Coupled with this, innovative packaging and extended product lines tailored to specific demographic groups are notably enhancing market penetration and growth.
Ibuprofen Market Analysis
The global ibuprofen market size reached US$ 93.1 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 117.3 Million, at a projected CAGR of 2.60% during 2023-2032. In the last quarter of 2023, the Ibuprofen market experienced a multitude of influencing factors across different regions that shaped the price dynamics significantly. In North America, one of the primary drivers of the declining Ibuprofen prices was the global economic uncertainty, which fueled concerns about inflation and potential recession. This broader economic sentiment led to cautious investment and purchasing behaviors, subsequently impacting the demand for pharmaceuticals including Ibuprofen. The market also faced a supply-demand imbalance, with a surplus of Ibuprofen due to reduced international demand, further driving down prices. The situation was compounded by the alignment of domestic prices with those of major exporting countries, reinforcing the downward trend. However, the scenario shifted dramatically towards the end of the quarter. Geopolitical tensions affecting major shipping routes such as the Red Sea and the Suez Canal, along with logistical challenges including container shortages and delayed vessel returns, led to increased freight costs. These heightened logistics expenses were swiftly reflected in Ibuprofen prices, culminating in a notable price increase in December. This abrupt change underscored the vulnerability of pharmaceutical supply chains to global trade disruptions and emphasized the interconnectedness of geopolitical events and healthcare markets.
Similarly, in the Asia Pacific region, the Ibuprofen market dynamics were characterized by initially low demand and ample supply, which pressed the prices downward. The APAC market, particularly in China, saw a consistent decrease in prices due to a combination of overstock and subdued demand both domestically and internationally. Manufacturers and distributors engaged in competitive pricing and destocking efforts, which sustained the price decline. However, the market witnessed a reversal in December when demand unexpectedly strengthened, leading to a rapid uptick in prices. This resurgence in demand could be attributed to a seasonal increase in pharmaceutical consumption or strategic stockpiling by distributors anticipating future demand increases or supply chain disruptions. This fluctuation highlighted the sensitivity of the Ibuprofen market to sudden shifts in consumer behavior and market sentiment. In Europe, the price trend mirrored those of APAC and North America to some extent, with a general decrease over the quarter followed by a sharp increase in December driven by a spike in demand. The initial low demand and high supply scenario facilitated a decrease in prices, but as the economic outlook in key markets like Germany began to stabilize slightly towards the year's end, coupled with rising global freight costs, the prices adjusted upwards. The European market’s dependency on imports made it particularly susceptible to shifts in global manufacturing and shipping landscapes, underscoring the complex interplay of local market conditions and international logistics in determining drug prices.
Browse Full Report: https://www.imarcgroup.com/ibuprofen-pricing-report
Key Points Covered in the Ibuprofen Pricing Report:
The report delivers the following key findings, alongside a comprehensive breakdown of prices by region:
- Ibuprofen Prices
- Ibuprofen Price Chart
- Ibuprofen Demand & Supply
- Ibuprofen Market Analysis
- Demand Supply Analysis by Type
- Demand Supply Analysis by Application
- Demand Supply Analysis of Raw Materials
- Ibuprofen Price Analysis
- Ibuprofen Industry Drivers, Restraints, and Opportunities
- Ibuprofen News and Recent developments
- Global Event Analysis
- List of Key Players
Regional Price Analysis:
- Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
- North America: United States and Canada
- Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
- Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco
Browse More Pricing Reports By IMARC Group:
Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.
About Us:
IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments